Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. The company also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. It is also involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; property investment. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Metrics to compare | TEL1 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTEL1PeersSector | |
---|---|---|---|---|
P/E Ratio | −52.8x | 22.3x | −0.5x | |
PEG Ratio | 0.18 | −0.62 | 0.00 | |
Price/Book | 2.6x | 1.9x | 2.6x | |
Price / LTM Sales | 6.0x | 2.4x | 3.3x | |
Upside (Analyst Target) | - | 3.4% | 43.4% | |
Fair Value Upside | Unlock | 18.0% | 7.1% | Unlock |